Hydroxychloroquine in the treatment of systemic lupus erythematosus
Reading time: 1 minute
Forty-seven patients with stabile SLE were randomised to continue hydroxychloroquine (n=25) or receive placebo (n=22) for 24 weeks
To continue reading this article, you must log in with your personal, organization, or group practice subscription.
For more information or to purchase a personal subscription, click below to see pricing.
Forty-seven patients with stabile SLE were randomised to continue hydroxychloroquine (n=25) or receive placebo (n=22) for 24 weeks
To continue reading this article, you must log in with your personal, organization, or group practice subscription.
For more information or to purchase a personal subscription, click below to see pricing.
|